Skip to main content
Cureus logoLink to Cureus
. 2026 Mar 10;18(3):c412. doi: 10.7759/cureus.c412

Correction: Biomarkers of Probiotic Therapy in Ulcerative Colitis: A Systematic Review of Mechanisms Underlying Remission

Mohammad E Farhad 1,, Ibrahim Belal 2, Mohamed Baana 3, Caroline Childs 4, Moussa Al-Rufayie 5
Editors: Alexander Muacevic, John R Adler
PMCID: PMC12978201  PMID: 41822248

Several studies cited in this article assessed a probiotic formulation previously known as VSL#3. The probiotic formulation that was assessed in these studies is now known by the generic name 'De Simone Formulation'. The current product known as VSL#3 is not the same formulation as the De Simone Formulation. The De Simone Formulation is available under the brand names Visbiome (USA) and Vivomixx (Europe).

No competing interests declared.


Articles from Cureus are provided here courtesy of Cureus Inc.

RESOURCES